We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Remains Undecided on Changes to Appraisal of New Drugs for Use by NHS
NICE Remains Undecided on Changes to Appraisal of New Drugs for Use by NHS
The UK’s health-cost watchdog said it’s not ready to change the way it appraises medicines and other technologies, but acknowledged that further consideration is needed on how new treatments are developed, evaluated and supported for adoption in the National Health Service (NHS).